<?xml version="1.0" encoding="UTF-8"?>
<p>Patients from the Division of Hematology and Oncology of the China Medical University Hospital were consecutively enrolled in the trial from September 1, 2015, onwards. The study protocol was approved by the Institutional Review Board of the China Medical University Hospital (DMR-105-005), and all participants provided informed consent. The trial protocol was made public on 
 <ext-link ext-link-type="uri" xlink:href="http://clincaltrials.gov" xmlns:xlink="http://www.w3.org/1999/xlink">clincaltrials.gov</ext-link> (identifier NCT02580071).
</p>
